431 related articles for article (PubMed ID: 21304982)
1. Response to 2009 pandemic influenza A (H1N1) vaccine in HIV-infected patients and the influence of prior seasonal influenza vaccination.
Soonawala D; Rimmelzwaan GF; Gelinck LB; Visser LG; Kroon FP
PLoS One; 2011 Jan; 6(1):e16496. PubMed ID: 21304982
[TBL] [Abstract][Full Text] [Related]
2. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR
Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995
[TBL] [Abstract][Full Text] [Related]
3. Responses to pandemic ASO3-adjuvanted A/California/07/09 H1N1 influenza vaccine in human immunodeficiency virus-infected individuals.
Kelly D; Burt K; Missaghi B; Barrett L; Keynan Y; Fowke K; Grant M
BMC Immunol; 2012 Aug; 13():49. PubMed ID: 22937824
[TBL] [Abstract][Full Text] [Related]
4. Long-term immunogenicity after one and two doses of a monovalent MF59-adjuvanted A/H1N1 Influenza virus vaccine coadministered with the seasonal 2009-2010 nonadjuvanted Influenza virus vaccine in HIV-infected children, adolescents, and young adults in a randomized controlled trial.
Viganò A; Giacomet V; Pariani E; Giani E; Manfredini V; Bedogni G; Erba P; Amendola A; Zanetti A; Zuccotti G
Clin Vaccine Immunol; 2011 Sep; 18(9):1503-9. PubMed ID: 21795458
[TBL] [Abstract][Full Text] [Related]
5. Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59-adjuvanted influenza vaccine in infants and young children.
Nolan T; Bravo L; Ceballos A; Mitha E; Gray G; Quiambao B; Patel SS; Bizjajeva S; Bock H; Nazaire-Bermal N; Forleo-Neto E; Cioppa GD; Narasimhan V
Vaccine; 2014 Oct; 32(46):6146-56. PubMed ID: 25223266
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of T and B memory cell responses elicited by the pandemic H1N1 vaccine in HIV-infected and HIV-uninfected individuals.
Sun P; Crum-Cianflone NF; Defang G; Williams M; Ganesan A; Agan BK; Lalani T; Whitman T; Brandt C; Burgess TH
Vaccine; 2017 Oct; 35(45):6103-6111. PubMed ID: 28987439
[TBL] [Abstract][Full Text] [Related]
7. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children.
Phongsamart W; Sirisanthana V; Wittawatmongkol O; Maleesatharn A; Sudjaritruk T; Chearskul P; Aurpibul L; Sirisanthana T; Chokephaibulkit K
Vaccine; 2011 Nov; 29(47):8705-11. PubMed ID: 21893147
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women.
Abzug MJ; Nachman SA; Muresan P; Handelsman E; Watts DH; Fenton T; Heckman B; Petzold E; Weinberg A; Levin MJ;
Clin Infect Dis; 2013 May; 56(10):1488-97. PubMed ID: 23378284
[TBL] [Abstract][Full Text] [Related]
10. Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees.
Herrera MT; Gonzalez Y; Juárez E; Hernández-Sánchez F; Carranza C; Sarabia C; Guzman-Beltran S; Manjarrez ME; Muñoz-Torrico M; Garcia-Garcia L; Sada E; Torres M
BMC Infect Dis; 2013 Nov; 13():544. PubMed ID: 24238117
[TBL] [Abstract][Full Text] [Related]
11. Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents.
Esposito S; Tagliaferri L; Daleno C; Valzano A; Picciolli I; Tel F; Prunotto G; Serra D; Galeone C; Plebani A; Principi N
Vaccine; 2011 Feb; 29(8):1677-82. PubMed ID: 21199699
[TBL] [Abstract][Full Text] [Related]
12. Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients.
Chang YT; Guo CY; Tsai MS; Cheng YY; Lin MT; Chen CH; Shen D; Wang JR; Sung JM
Vaccine; 2012 Jul; 30(33):5009-18. PubMed ID: 22658967
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: data from two multicentre randomised trials.
Peeters M; Regner S; Vaman T; Devaster JM; Rombo L
Vaccine; 2012 Oct; 30(45):6483-91. PubMed ID: 22885014
[TBL] [Abstract][Full Text] [Related]
14. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine.
Weinberg A; Muresan P; Richardson KM; Fenton T; Dominguez T; Bloom A; Watts DH; Abzug MJ; Nachman SA; Levin MJ;
PLoS One; 2015; 10(4):e0122431. PubMed ID: 25874544
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of an MF59(®)-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly.
Vesikari T; Forstén A; Herbinger KH; Cioppa GD; Beygo J; Borkowski A; Groth N; Bennati M; von Sonnenburg F
Vaccine; 2012 Feb; 30(7):1388-96. PubMed ID: 22192847
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of a monovalent MF59®-adjuvanted A/H1N1 vaccine in HIV-infected children and young adults.
Palma P; Romiti ML; Bernardi S; Pontrelli G; Mora N; Santilli V; Tchidjou HK; Aquilani A; Cotugno N; Alghisi F; Lucidi V; Rossi P; Douagi I
Biologicals; 2012 Mar; 40(2):134-9. PubMed ID: 22261282
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of in vitro cross-reactivity to avian H5N1 and pandemic H1N1 2009 influenza following prime boost regimens of seasonal influenza vaccination in healthy human subjects: a randomised trial.
Bethell D; Saunders D; Jongkaewwattana A; Kramyu J; Thitithayanont A; Wiboon-ut S; Yongvanitchit K; Limsalakpetch A; Kum-Arb U; Uthaimongkol N; Garcia JM; Timmermans AE; Peiris M; Thomas S; Engering A; Jarman RG; Mongkolsirichaikul D; Mason C; Khemnu N; Tyner SD; Fukuda MM; Walsh DS; Pichyangkul S
PLoS One; 2013; 8(3):e59674. PubMed ID: 23555741
[TBL] [Abstract][Full Text] [Related]
18. Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.
McVernon J; Laurie K; Barr I; Kelso A; Skeljo M; Nolan T
Influenza Other Respir Viruses; 2011 Jan; 5(1):7-11. PubMed ID: 21138535
[TBL] [Abstract][Full Text] [Related]
19. Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients.
Fairhead T; Hendren E; Tinckam K; Rose C; Sherlock CH; Shi L; Crowcroft NS; Gubbay JB; Landsberg D; Knoll G; Gill J; Kumar D
Transpl Infect Dis; 2012 Dec; 14(6):575-83. PubMed ID: 22999005
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and tolerability after two doses of non-adjuvanted, whole-virion pandemic influenza A (H1N1) vaccine in HIV-infected individuals.
Lagler H; Grabmeier-Pfistershammer K; Touzeau-Römer V; Tobudic S; Ramharter M; Wenisch J; Gualdoni GA; Redlberger-Fritz M; Popow-Kraupp T; Rieger A; Burgmann H
PLoS One; 2012; 7(5):e36773. PubMed ID: 22629330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
